Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.04.2023 | Case report

Eltrombopag

Various toxicities: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Iino M, et al. Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naive patients with aplastic anemia: an observational retrospective analysis in a single institution. Hematology 27 : 360-366, No. 1, 2022. Available from: URL: http://doi.org/10.1080/16078454.2022.2045725 Iino M, et al. Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naive patients with aplastic anemia: an observational retrospective analysis in a single institution. Hematology 27 : 360-366, No. 1, 2022. Available from: URL: http://​doi.​org/​10.​1080/​16078454.​2022.​2045725
Metadaten
Titel
Eltrombopag
Various toxicities: 2 case reports
Publikationsdatum
01.04.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-37615-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Rituximab

Case report

Bevacizumab